Drug Search Results
More Filters [+]

Almagate

Alternative Names: almagate, almax
Latest Update: 2024-11-27
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: pepsin Blocker

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Chile | Colombia | Germany | India | Korea | Mexico | Peru | Spain | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Almirall
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Almagate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Heartburn

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

M-00ALM-04

P4

Unknown Status

Heartburn

2026-11-01

ChiCTR-IPR-15005905

N/A

Not yet recruiting

Gastritis

2017-07-01

Recent News Events